481 related articles for article (PubMed ID: 2236972)
1. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC
Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444
[TBL] [Abstract][Full Text] [Related]
4. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
Keeler R
Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491
[TBL] [Abstract][Full Text] [Related]
5. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
Hoyer JR; Mauer SM; Michael AF
J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
[TBL] [Abstract][Full Text] [Related]
6. Epithelial sodium channel (ENaC) subunit mRNA and protein expression in rats with puromycin aminonucleoside-induced nephrotic syndrome.
Audigé A; Yu ZR; Frey BM; Uehlinger DE; Frey FJ; Vogt B
Clin Sci (Lond); 2003 Apr; 104(4):389-95. PubMed ID: 12653683
[TBL] [Abstract][Full Text] [Related]
7. Serum and urinary ceruloplasmin in experimental nephrotic syndrome.
Mainero A; Cruz C; Pedraza-Chaverrí J
Clin Invest Med; 1992 Aug; 15(4):295-300. PubMed ID: 1516286
[TBL] [Abstract][Full Text] [Related]
8. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
10. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
Bistrup C; Thiesson HC; Jensen BL; Skøtt O
Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
[TBL] [Abstract][Full Text] [Related]
11. Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats.
Pinto JA; Brewer DB
J Pathol; 1975 Jul; 116(3):149-64. PubMed ID: 1104792
[TBL] [Abstract][Full Text] [Related]
12. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
Sellars L; Shore AC; Mott V; Wilkinson R
Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
[TBL] [Abstract][Full Text] [Related]
13. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
14. Effects of low protein diet in puromycin aminonucleoside-induced nephrotic rats.
Shibasaki T; Gomi H; Ishimoto F; Sakai O
Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):871-5. PubMed ID: 2250404
[TBL] [Abstract][Full Text] [Related]
15. Effect of spironolactone on the renin-aldosterone system in rats.
Jiménez W; Martínez-Pardo A; Arroyo V; Gaya J; Rivera F
Rev Esp Fisiol; 1988 Sep; 44(3):257-63. PubMed ID: 3068736
[TBL] [Abstract][Full Text] [Related]
16. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
[TBL] [Abstract][Full Text] [Related]
17. [The role of the renin-angiotensin system in the pathogenesis of nephrotic syndrome].
Kutyrina IM; Klepikov PV; Tareeva IE
Ter Arkh; 1988; 60(6):32-4. PubMed ID: 3061050
[TBL] [Abstract][Full Text] [Related]
18. Effects of uroguanylin on natriuresis in experimental nephrotic rats.
Baba A; Fujimoto S; Kikuchi M; Kita T; Kitamura K
Nephrology (Carlton); 2009 Feb; 14(1):80-5. PubMed ID: 19054333
[TBL] [Abstract][Full Text] [Related]
19. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
Kaplan BS; Renaud L; Drummond KN
Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918
[TBL] [Abstract][Full Text] [Related]
20. Proteinuric diseases with sodium retention: Is plasmin the link?
Svenningsen P; Skøtt O; Jensen BL
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):117-24. PubMed ID: 21466573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
